Park. "We're excited to continue to expand on these designs for potential treatment of glioblastoma and, in the future, for other types of cancer that haven't responded to immunotherapy due to ...

Weiner, Ph.D. — Executive Vice President, director of the Vaccine & Immunotherapy Center and W.W. Smith Charitable Trust Distinguished Professor in Cancer Research — and his lab have successfully ...

“We’re excited to continue to expand on these designs for potential treatment of glioblastoma and, in the future, for other types of cancer that haven’t responded to immunotherapy due to ...

Nov. 7, 2024 — Researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy. The strategy, which they demonstrated in cells in the lab ...

Weiner, Ph.D. — Executive Vice President, director of the Vaccine & Immunotherapy Center and ... improves survival and reduces tumor burden in glioblastoma. Their findings were published in ...